Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

  • RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    • News

  • BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    • News

  • AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    • News

  • Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    • News

  • Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    • News

  • FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    • News

  • Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    • News

VIP ceases glove production as demand falls, after tooting their own horn for two years

  • In News
  • December 2, 2022
  • Alinda Gupta
VIP ceases glove production as demand falls, after tooting their own horn for two years

Remember when Frank Sinatra caught a cold and couldn’t perform? He might as well have thrown in the towel and joined the crowd outside Nat King Cole’s venue; his voice was his identity. The only difference between Sinatra and nitrile glove manufacturer VIP Gloves (ASX: VIP) is that Sinatra had a personality beyond singing. VIP Gloves’ personality is gloves. And they are not going to be making them from now on.

When Covid began in 2020, the Company anticipated a 50 per cent increase in its average selling price, what with the growing demand and all. In May 2021, when the Malaysian government initiated a total lockdown, VIP boasted about being an “essential service” and said glove production wouldn’t be affected. All was rosy in the medical glove compartment until this year. In its quarterly report in June 2022, the Company reported a 24 per cent quarter-on-quarter reduction in glove production output, a 28 per cent decrease in customer receipts and a 3 per cent decline in price. It went from exercising unhinged glory to cautious optimism.

Now, it has temporarily ceased all of its glove manufacturing operations.

It listed a range of factors to justify its decision: the poor market demand for nitrile gloves, low average selling prices of gloves, rising raw material costs, rapidly increasing gas utility costs caused mainly by international demand for gas due to the Russian-Ukraine conflict, and an increase in the minimum wage set by the Malaysian government—whew—led the Company to this point.

Its June 2022 quarterly report also pointed to increased competition hindering its efforts. As a result, VIP had to halt the construction of the second factory on adjacent land to the current factory, blaming the current and unprecedented global glove oversupply market conditions. Too many gloves, too few wearers.

Nitrile gloves are those typically blue medical gloves you must have seen doctors, nurses and even average citizens wear during Covid. They are meant to protect your hands from bacteria. Naturally, their demand rose during the pandemic as people invested heavily in keeping themselves safe. This urged many other companies to explore the nitrile glove space, too. However, fewer people are interested now that the world is coming out of Covid.

This is not the Company’s first production halt. In the September quarter, too, it temporarily ceased production of its 3.5gm nitrile gloves line whilst it sought to expand into alternative types of gloves and create new glove markets. Compared to the June quarter, as of September, its sales revenue from nitrile gloves fell by a whopping 85%. Moreover, receipts from customers fell by 97% to only $100k.

VIP expects the glove demand to rise again in 2023 once people eventually run out. Since they are disposable, there is a recurring demand for them. Currently, for the Company, it’s a “wait and watch, then pounce” game, wherein it will be waiting with its old stock of gloves once people return, somewhat like a devastated but hopeful lover.

VIP Gloves’s cessation of glove production is a classic case study in humility and thinking long-term because you never know when the tides might turn on you. Sinatra recovered from his cold and returned to the stage, will VIP, too?

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  •  
  •  
  •  
  •  
  • ASX: VIP
  • manufacturing
  • nitrile gloves
  • vip
  • VIP gloves
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.